Cresco Labs is trading at $0.60 (-5.15%) as cannabis-sector pressure continued amid uncertainty over the paused federal marijuana-rescheduling process.
- The DEA judge allowed additional briefs but did not reopen the hearing.
- Cresco Labs announced a new Kentucky dispensary opening on October 23; available coverage does not link the opening to the decline.